Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.21 USD | +1.02% | +8.41% | -23.75% |
Sales 2024 * | 369B 28,818B | Sales 2025 * | 387B 30,244B | Capitalization | 75.59B 5,905B |
---|---|---|---|---|---|
Net income 2024 * | 7.47B 583B | Net income 2025 * | 8.78B 686B | EV / Sales 2024 * | 0.34 x |
Net Debt 2024 * | 49.74B 3,886B | Net Debt 2025 * | 46.18B 3,608B | EV / Sales 2025 * | 0.31 x |
P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
8.97
x | Employees | 259,500 |
Yield 2024 * |
4.42% | Yield 2025 * |
4.6% | Free-Float | 70.66% |
Latest transcript on CVS Health Corporation
1 day | +1.02% | ||
1 week | +8.41% | ||
Current month | +1.02% | ||
1 month | +7.71% | ||
3 months | -18.46% | ||
6 months | -12.08% | ||
Current year | -23.75% |
Managers | Title | Age | Since |
---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 27/11/18 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 31/01/22 |
Tilak Mandadi
CTO | Chief Tech/Sci/R&D Officer | - | 24/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 19/01/11 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 27/11/18 |
Mary Schapiro
BRD | Director/Board Member | 68 | 09/05/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.92% | 17 M€ | +7.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
03/06/24 | 60.21 | +1.02% | 17,087,324 |
31/05/24 | 59.6 | +6.35% | 22,366,748 |
30/05/24 | 56.04 | +4.42% | 16,154,336 |
29/05/24 | 53.67 | +0.07% | 16,543,442 |
Delayed Quote Nyse, June 03, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.75% | 75.59B | |
+22.91% | 87.14B | |
+1.06% | 26.78B | |
+3.92% | 17.89B | |
-14.20% | 16.44B | |
+2.34% | 15.68B | |
+76.91% | 13.06B | |
+72.91% | 13.3B | |
+38.99% | 12.77B | |
+22.41% | 12.49B |
- Stock Market
- Equities
- CVS Stock